This report aims to provide detailed insights into the NGS-based RNA-sequencing market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
Expected Revenue Growth:
The NGS-based RNA-sequencing industry size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0% during the forecast period.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816
Key Factors Driving Market Growth:
Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.
The expression profiling analysis segment accounted for the largest share of the NGS-based RNA-sequencing industry, by application, in 2018
Based on application, the NGS-Based RNA-Sequencing Market is segmented into expression profiling analysis, small RNA sequencing, De Novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share of the RNA Sequencing Market. The dominant market position of this segment is attributed mainly to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases. These factors will continue to propel the demand for expression profiling analysis to provide specific treatment options in the RNA Sequencing market during the forecast period.
The nanopore segment is expected to register the highest growth in the NGS-based RNA-sequencing market, by type, during the forecast period
Based on technology, the NGS-based RNA-sequencing industry is segmented into sequencing by synthesis, ion semiconductor sequencing, single molecular real-time sequencing, and nanopore sequencing. Nanopore sequencing technology registers the highest growth rate in the market as it is the only sequencing technology with direct RNA sequencing capabilities and facilitates sequencing of full-length RNA strands and modified RNA nucleotides using a simple library prep, without the need of conversion to double-stranded DNA.
North America dominated the NGS-based RNA-sequencing market
North America accounted for the largest share of RNA Sequencing market in 2018. The large share of this region is the growing prevalence of target diseases, government support through funds for genomics research, advancements in RNA-Seq products, increasing research on cancer & inherited rare diseases, and the strong presence of key players such as Illumina (US), Thermo Fisher (US), and Agilent Technologies (US) in this region.
Request For Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=102977816
Key Players:
Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. among others are the major players operating in the NGS-based RNA-sequencing market.
Illumina dominates the RNA sequencing market with its technologically advanced & innovative platforms and associated sequencing products. The company’s product portfolio includes a wide range of highly interconnected products, including sequencing, genotyping, gene expression, and molecular diagnostic products. Illumina also offers NGS-based RNA sequencing services which further strengthens its market position. Over the past three years, Illumina has launched several products in the market.
NGS-Based RNA-Sequencing Market: Emerging Industry Trends and Opportunities
The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain.
According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period.
However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018.
The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips.
It would contribute to the market growth in the forthcoming years.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market.
They are as follows:uFluidixPerkin ElmerFluidigmBlacktrace Holdings Ltd. (Dolomite Microfluidic)MicronitBioFluidix GmbHFluigentALine, Inc.PhilipsThe report consists of the latest releases and new mechanical enhancements to engage the consumers to settle on instructed business decisions, design, and complete their required executions.
http://www.lovelacebiomedical.org/services/biotechnology-lab/Lovelace has a pioneer biotechnology testing lab in the USA and we have huge experience in biotechnology to perform all your biotechnology research.
The Mucus Clearance Devices Market is assessed to have solid development later on.
The locale likewise has the most noteworthy understudy populace, and with propelling advancements, there is a developing interest for eLearning and distance training.
This drives the healthcare business sector to meet broadened instructive prerequisites across different nations in the APAC district, like Australia and New Zealand (ANZ), Japan, China, Singapore, and India.Attributable to the flare-up of COVID-19, different nations follow severe lockdowns, closures, and portability limitations to stay away from the spread of the infection.
Merchants have encountered appeal for Smart Learning arrangements during 2020.
Conclusion of lines, rigid lockdowns, and inventory network issues go about as limiting elements for the on location arrangement of Smart Learning arrangements.
The commercialization of Mucus Clearance Devices Market is relied upon to drive market development for an enormous scope.
The report Global Blue Biotechnology Market covers the analysis and forecast of the blue biotechnology market on global as well as regional level, provides historic data of 2016 along with the forecast for the period between 2017 and 2025.The study provides a detailed view of the blue biotechnology market, by segmenting it based on by product type, by application, by end- user and regional demand.
Robust growth of drug discovery in the past several years propels the growth for the blue biotechnologys market.
Growing usage of algae along with other bacteria for producing a new drug is another prime factor driving the market demand.
Extensive use of blue biotechnologys in end-user industries such as pharmaceutical, research organization, healthcare, and others boosts the demand of this market.Leading Market Players of Global blue biotechnology market:Aker BiomarineCellgen Biologicals Pvt Ltd.Donald Danforth Plant Science CenterGeomarine BiotechnologiesGlycomarMarinovaNurture Aqua Technology Pvt.New England BiolabsPicesPml Application Ltd.Global blue biotechnology market has been segmented into:By Product TypePharmaBiofuelsFoodEnzymesBiopolymersBy ApplicationVaccine developmentDrug findingGenomics By End- UserPharmaceutical companiesBiotechnology companiesResearch organizationHealthcare centreBy Regions:North America Europe Asia Pacific Middle East and Africa Latin America Rest of Latin America About Aarkstore EnterpriseAarkstore curates global market research reports from various industry verticals and serves businesses worldwide.
As market research report resellers, we at Aarkstore, partner with established publishers for both; syndicated data and customized reports.
The market research data supplied by us is up-to-date and reliable for current day industry analysis and future market forecasts equally.Avail market research reports from us and gathers critical information about customer preferences, market requirements, key drivers and challenges for your business to align your strategies with them.
1 March 2019, The global Liquid Biopsy Market is projected to witness substantial growth over the forecast period (from 2017 to 2025) owing to advancement in liquid biopsy tests and extensive R by major companies.
Moreover, highly invasive nature and frequent complications associated with tissue biopsy and advancements in Next-Generation Sequencing (NGS) is anticipated to fuel demand for liquid biopsy in coming years.Liquid biopsies make use of bio fluid samples, such as blood, urine sample, tissue fluids, and saliva.
The technology is widely used in molecular health monitoring, therapy selection for Metastatic Breast Cancer (MBS), and other related cancers.
MBS is likely to emerge as a leading application over the forecast period as a result of growing cases of metastatic cancer across the world.
PCR-based sequencing is used for analysis of mutations in disease-specific genes, whereas NGS testing is used for simultaneous analysis of multiple diseases.
Rising awareness about benefits of multiple-gene analysis and NGS is projected to have a positive impact on the market growth over the next few years.The market can be segmented on the basis of geography as North America, Latin America, Asia Pacific, Europe, and MEA.
Rising extensive research for better healthcare is driving the growth of global molecular diagnostics market in the forecast period, 2022-2026.According to TechSci Research report, “Global Molecular Diagnostics Market By Products and Services (Reagents and Kits, Instruments, Services and Software), By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others), By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others), By End User (Hospitals, Academic & Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026”, the global molecular diagnostics market is projected to reach USD80.45 billion by 2026, owing to increasing geriatric population and rising cases of infectious diseases including COVID-19.Furthermore, geriatric population is more prone to get infected with chronic and target diseases like cancer, lung diseases, Parkinson’s disease, heart diseases, diabetes, and require molecular diagnostics that would drive the market growth in the upcoming five years.
Diseases like cancer, viral infections, neurological diseases including Alzheimer’s and Dementia are very risk prone for the old age patients.
All these factors together with rising COVID-19 cases are anticipated to support the growth of the global molecular diagnostic market in the next five years.
Moreover, rising cases of COVID-19 during 2020 and 2021 have raised the demand for RT-PCR testing which is likely to have a positive influence towards the growth of the market.A collection of techniques that are used to analyze the biological markers in genome and proteome, and to understand the cells expressions as proteins while applying molecular biology to medical testing.
Molecular diagnostics have widespread applications in neurological disorders, neuro degenerative diseases like Alzheimer’s, Parkinson’s, dementia, brain tumors, chronic depression, and more due to early and effective diagnosis.Browse over 138 market data Figures spread through 110 Pages and an in-depth TOC on “Global Molecular Diagnostics Market"https://www.techsciresearch.com/report/molecular-diagnostics-market/7463.htmlThe global molecular diagnostics market is segmented into products and services, technology, application, end user, regional distribution, and competitional landscape.
Procedures like extraction of the genetic material, amplification of the genetic material, and separation of the proteins and other biomolecules require reagents and kits that can aid the research of the respective procedures.
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market.The immunohistochemistry market is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.
Antibodies segment to dominate the global immunohistochemistry marketBased on products, the market is segmented into antibodies, reagents, kits, and equipment.
In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market.
The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have led to the rapid discovery of thousands of potential antibodies.Diagnostics segment accounted for largest share of immunohistochemistry marketImmunohistochemistry market is categorized into two application segments, namely, diagnostics and drug testing.
The global market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases.
The method of identifying the genetic code of an organism into the DNA sequence is known as DNA sequencing.
It refers to any approach or procedure used to determine how the four bases in DNA are arranged in a DNA sequence.
Chemical ionisation and connection of DNA sequencing equipment and services to an alkaline base are used in other approaches.The advantages of DNA sequencing equipment and services over alternative technologies are numerous.
For starters, precise measurements can be made without changing the DNA structure.
It also identifies regions of DNA sequence variation.
This allows DNA sequencing equipment and services to be used in a variety of fields of DNA biology, including inherited disorders and ageing.
The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain.
According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period.
However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018.
The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips.
It would contribute to the market growth in the forthcoming years.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market.
They are as follows:uFluidixPerkin ElmerFluidigmBlacktrace Holdings Ltd. (Dolomite Microfluidic)MicronitBioFluidix GmbHFluigentALine, Inc.PhilipsThe report consists of the latest releases and new mechanical enhancements to engage the consumers to settle on instructed business decisions, design, and complete their required executions.
http://www.lovelacebiomedical.org/services/biotechnology-lab/Lovelace has a pioneer biotechnology testing lab in the USA and we have huge experience in biotechnology to perform all your biotechnology research.
The Mucus Clearance Devices Market is assessed to have solid development later on.
The locale likewise has the most noteworthy understudy populace, and with propelling advancements, there is a developing interest for eLearning and distance training.
This drives the healthcare business sector to meet broadened instructive prerequisites across different nations in the APAC district, like Australia and New Zealand (ANZ), Japan, China, Singapore, and India.Attributable to the flare-up of COVID-19, different nations follow severe lockdowns, closures, and portability limitations to stay away from the spread of the infection.
Merchants have encountered appeal for Smart Learning arrangements during 2020.
Conclusion of lines, rigid lockdowns, and inventory network issues go about as limiting elements for the on location arrangement of Smart Learning arrangements.
The commercialization of Mucus Clearance Devices Market is relied upon to drive market development for an enormous scope.
Rising extensive research for better healthcare is driving the growth of global molecular diagnostics market in the forecast period, 2022-2026.According to TechSci Research report, “Global Molecular Diagnostics Market By Products and Services (Reagents and Kits, Instruments, Services and Software), By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others), By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others), By End User (Hospitals, Academic & Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026”, the global molecular diagnostics market is projected to reach USD80.45 billion by 2026, owing to increasing geriatric population and rising cases of infectious diseases including COVID-19.Furthermore, geriatric population is more prone to get infected with chronic and target diseases like cancer, lung diseases, Parkinson’s disease, heart diseases, diabetes, and require molecular diagnostics that would drive the market growth in the upcoming five years.
Diseases like cancer, viral infections, neurological diseases including Alzheimer’s and Dementia are very risk prone for the old age patients.
All these factors together with rising COVID-19 cases are anticipated to support the growth of the global molecular diagnostic market in the next five years.
Moreover, rising cases of COVID-19 during 2020 and 2021 have raised the demand for RT-PCR testing which is likely to have a positive influence towards the growth of the market.A collection of techniques that are used to analyze the biological markers in genome and proteome, and to understand the cells expressions as proteins while applying molecular biology to medical testing.
Molecular diagnostics have widespread applications in neurological disorders, neuro degenerative diseases like Alzheimer’s, Parkinson’s, dementia, brain tumors, chronic depression, and more due to early and effective diagnosis.Browse over 138 market data Figures spread through 110 Pages and an in-depth TOC on “Global Molecular Diagnostics Market"https://www.techsciresearch.com/report/molecular-diagnostics-market/7463.htmlThe global molecular diagnostics market is segmented into products and services, technology, application, end user, regional distribution, and competitional landscape.
Procedures like extraction of the genetic material, amplification of the genetic material, and separation of the proteins and other biomolecules require reagents and kits that can aid the research of the respective procedures.
The report Global Blue Biotechnology Market covers the analysis and forecast of the blue biotechnology market on global as well as regional level, provides historic data of 2016 along with the forecast for the period between 2017 and 2025.The study provides a detailed view of the blue biotechnology market, by segmenting it based on by product type, by application, by end- user and regional demand.
Robust growth of drug discovery in the past several years propels the growth for the blue biotechnologys market.
Growing usage of algae along with other bacteria for producing a new drug is another prime factor driving the market demand.
Extensive use of blue biotechnologys in end-user industries such as pharmaceutical, research organization, healthcare, and others boosts the demand of this market.Leading Market Players of Global blue biotechnology market:Aker BiomarineCellgen Biologicals Pvt Ltd.Donald Danforth Plant Science CenterGeomarine BiotechnologiesGlycomarMarinovaNurture Aqua Technology Pvt.New England BiolabsPicesPml Application Ltd.Global blue biotechnology market has been segmented into:By Product TypePharmaBiofuelsFoodEnzymesBiopolymersBy ApplicationVaccine developmentDrug findingGenomics By End- UserPharmaceutical companiesBiotechnology companiesResearch organizationHealthcare centreBy Regions:North America Europe Asia Pacific Middle East and Africa Latin America Rest of Latin America About Aarkstore EnterpriseAarkstore curates global market research reports from various industry verticals and serves businesses worldwide.
As market research report resellers, we at Aarkstore, partner with established publishers for both; syndicated data and customized reports.
The market research data supplied by us is up-to-date and reliable for current day industry analysis and future market forecasts equally.Avail market research reports from us and gathers critical information about customer preferences, market requirements, key drivers and challenges for your business to align your strategies with them.
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market.The immunohistochemistry market is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.
Antibodies segment to dominate the global immunohistochemistry marketBased on products, the market is segmented into antibodies, reagents, kits, and equipment.
In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market.
The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have led to the rapid discovery of thousands of potential antibodies.Diagnostics segment accounted for largest share of immunohistochemistry marketImmunohistochemistry market is categorized into two application segments, namely, diagnostics and drug testing.
The global market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases.
The method of identifying the genetic code of an organism into the DNA sequence is known as DNA sequencing.
It refers to any approach or procedure used to determine how the four bases in DNA are arranged in a DNA sequence.
Chemical ionisation and connection of DNA sequencing equipment and services to an alkaline base are used in other approaches.The advantages of DNA sequencing equipment and services over alternative technologies are numerous.
For starters, precise measurements can be made without changing the DNA structure.
It also identifies regions of DNA sequence variation.
This allows DNA sequencing equipment and services to be used in a variety of fields of DNA biology, including inherited disorders and ageing.
1 March 2019, The global Liquid Biopsy Market is projected to witness substantial growth over the forecast period (from 2017 to 2025) owing to advancement in liquid biopsy tests and extensive R by major companies.
Moreover, highly invasive nature and frequent complications associated with tissue biopsy and advancements in Next-Generation Sequencing (NGS) is anticipated to fuel demand for liquid biopsy in coming years.Liquid biopsies make use of bio fluid samples, such as blood, urine sample, tissue fluids, and saliva.
The technology is widely used in molecular health monitoring, therapy selection for Metastatic Breast Cancer (MBS), and other related cancers.
MBS is likely to emerge as a leading application over the forecast period as a result of growing cases of metastatic cancer across the world.
PCR-based sequencing is used for analysis of mutations in disease-specific genes, whereas NGS testing is used for simultaneous analysis of multiple diseases.
Rising awareness about benefits of multiple-gene analysis and NGS is projected to have a positive impact on the market growth over the next few years.The market can be segmented on the basis of geography as North America, Latin America, Asia Pacific, Europe, and MEA.